Centessa Pharmaceuticals plc Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Centessa Pharmaceuticals plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Centessa Pharmaceuticals plc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $8.45M, a 11.8% increase year-over-year.
  • Centessa Pharmaceuticals plc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $32.6M, a 14.2% increase year-over-year.
  • Centessa Pharmaceuticals plc annual Share-based Payment Arrangement, Expense for 2023 was $29.4M, a 17.7% increase from 2022.
  • Centessa Pharmaceuticals plc annual Share-based Payment Arrangement, Expense for 2022 was $25M, a 68.1% increase from 2021.
  • Centessa Pharmaceuticals plc annual Share-based Payment Arrangement, Expense for 2021 was $14.9M, a 4320% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $29.4M +$4.43M +17.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $25M +$10.1M +68.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $14.9M +$14.5M +4320% Jan 30, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $336K +$100K +42.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $236K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.